Molecular Basis of Pathogenesis of Coronaviruses: A Comparative Genomics Approach to Planetary Health to Prevent Zoonotic Outbreaks in the 21st Century
- PMID: 32940573
- DOI: 10.1089/omi.2020.0131
Molecular Basis of Pathogenesis of Coronaviruses: A Comparative Genomics Approach to Planetary Health to Prevent Zoonotic Outbreaks in the 21st Century
Abstract
In the first quarter of the 21st century, we are already facing the third emergence of a coronavirus outbreak, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) responsible for the coronavirus disease 2019 (COVID-19) pandemic. Comparative genomics can inform a deeper understanding of the pathogenesis of COVID-19. Previous strains of coronavirus, SARS-CoV, and Middle-East respiratory syndrome-coronavirus (MERS-CoV), have been known to cause acute lung injuries in humans. SARS-CoV-2 shares genetic similarity with SARS-CoV with some modification in the S protein leading to their enhanced binding affinity toward the angiotensin-converting enzyme 2 (ACE2) receptors of human lung cells. This expert review examines the features of all three coronaviruses through a conceptual lens of comparative genomics. In particular, the life cycle of SARS-CoV-2 that enables its survival within the host is highlighted. Susceptibility of humans to coronavirus outbreaks in the 21st century calls for comparisons of the transmission history, hosts, reservoirs, and fatality rates of these viruses so that evidence-based and effective planetary health interventions can be devised to prevent future zoonotic outbreaks. Comparative genomics offers new insights on putative and novel viral targets with an eye to both therapeutic innovation and prevention. We conclude the expert review by (1) articulating the lessons learned so far, whereas the research is still being actively sought after in the field, and (2) the challenges and prospects in deciphering the linkages among multiomics biological variability and COVID-19 pathogenesis.
Keywords: COVID-19; MERS-CoV; SARS-CoV; SARS-CoV-2; comparative genomics; planetary health.
Similar articles
-
Angiotensin-converting enzyme 2: The old door for new severe acute respiratory syndrome coronavirus 2 infection.Rev Med Virol. 2020 Sep;30(5):e2122. doi: 10.1002/rmv.2122. Epub 2020 Jun 30. Rev Med Virol. 2020. PMID: 32602627 Free PMC article. Review.
-
[Source of the COVID-19 pandemic: ecology and genetics of coronaviruses (Betacoronavirus: Coronaviridae) SARS-CoV, SARS-CoV-2 (subgenus Sarbecovirus), and MERS-CoV (subgenus Merbecovirus).].Vopr Virusol. 2020;65(2):62-70. doi: 10.36233/0507-4088-2020-65-2-62-70. Vopr Virusol. 2020. PMID: 32515561 Review. Russian.
-
Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review.APMIS. 2020 Jun;128(6):423-432. doi: 10.1111/apm.13047. APMIS. 2020. PMID: 32363707 Review.
-
Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2.J Med Virol. 2020 Jun;92(6):595-601. doi: 10.1002/jmv.25726. Epub 2020 Mar 11. J Med Virol. 2020. PMID: 32100877 Free PMC article.
-
Facing the COVID-19 outbreak: What should we know and what could we do?J Med Virol. 2020 Jun;92(6):536-537. doi: 10.1002/jmv.25720. Epub 2020 Mar 5. J Med Virol. 2020. PMID: 32091134 Free PMC article. No abstract available.
Cited by
-
HLA-B27 did not protect against COVID-19 in patients with axial spondyloarthritis - data from the ReumaCov-Brasil Registry.Adv Rheumatol. 2023 Nov 29;63(1):56. doi: 10.1186/s42358-023-00340-0. Adv Rheumatol. 2023. PMID: 38031143
-
Antibody Response against Severe Acute Respiratory Syndrome Coronavirus 2 Messenger Ribonucleic Acid Vaccines in Infected Individuals: A Systematic Review.Malays J Med Sci. 2023 Aug;30(4):8-24. doi: 10.21315/mjms2023.30.4.2. Epub 2023 Aug 24. Malays J Med Sci. 2023. PMID: 37655145 Free PMC article. Review.
-
The Complex Association between COPD and COVID-19.J Clin Med. 2023 May 31;12(11):3791. doi: 10.3390/jcm12113791. J Clin Med. 2023. PMID: 37297985 Free PMC article. Review.
-
Global prevalence of coronavirus disease 2019 reinfection: a systematic review and meta-analysis.BMC Public Health. 2023 Apr 28;23(1):778. doi: 10.1186/s12889-023-15626-7. BMC Public Health. 2023. PMID: 37118717 Free PMC article.
-
Therapeutic Modalities for Asthma, COPD, and Pathogenesis of COVID-19: Insights from the Special Issue.J Clin Med. 2022 Aug 3;11(15):4525. doi: 10.3390/jcm11154525. J Clin Med. 2022. PMID: 35956140 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous